| Name | Title | Contact Details |
|---|---|---|
Jared Burgess |
Director of Information Technology and Infrastructure | Profile |
Chris Porter |
Director of Information Technology and Infrastructure | Profile |
The Abacus Medicine Group creates better access to medicine. We help life-critical medicines become more widely available.
DiaMedica Inc., a development stage biopharmaceutical company, is engaged in the discovery and development of drugs for the treatment of diabetes and related diseases. The company`s lead clinical stage compound is DM199, a recombinant human protein known as rhKLK1, which is under phase I/II clinical trials for the treatment of Type 1 and Type 2 diabetes and associated complications. It is also developing DM204, a monoclonal antibody that is in preclinical development for the treatment of Type 2 diabetes; and DMDx, a chronic kidney disease assay to detect levels of the tissue kallikrein-1 protein in urine and to predict the rate of kidney disease progression. The company was formerly known as Diabex Inc. and changed its name to DiaMedica Inc. in February 2001. DiaMedica Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Fowler's Pharmacy is a Hastings, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
It is the goal of Women's International Pharmacy, Inc. to provide excellent service and quality compounded prescriptions to our customers. At Women's International Pharmacy, Inc., we are dedicated to providing custom compounded doses of bioidentical
American Health Packaging is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.